Media Center

Recent News

06/13/18ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 20, 2018Printer Friendly Version
06/06/18ACADIA Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference on June 13, 2018Printer Friendly Version
05/08/18ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018Printer Friendly Version
05/04/18ACADIA Pharmaceuticals Reports First Quarter 2018 Financial ResultsPrinter Friendly Version
05/02/18ACADIA Pharmaceuticals Announces Appointment of Elena Ridloff, CFA, as Senior Vice President, Investor RelationsPrinter Friendly Version
2018 | 2017 | 2016 | Archive

Company Information

Annual Report
Corporate Presentation


Scientific Publications

Pimavanserin for patients with Parkinson's disease psychosis: a randomized, placebo-controlled phase 3 trial. The Lancet, 383, 533-540 (2014).